Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-016921
Filing Date
2016-01-04
Accepted
2016-01-04 16:45:17
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5168
  Complete submission text file 0001179110-16-016921.txt   6751
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
Ocata Therapeutics, Inc. (Issuer) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 98 MONTVALE RD NEWTON MA 02459
Business Address
LANGER ROBERT (Reporting) CIK: 0001239757 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36855 | Film No.: 161318651